Your browser doesn't support javascript.
loading
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis.
Pesenti, Chiara; Beltrame, Luca; Velle, Angelo; Fruscio, Robert; Jaconi, Marta; Borella, Fulvio; Cribiù, Fulvia Milena; Calura, Enrica; Venturini, Lara Veronica; Lenoci, Deborah; Agostinis, Federico; Katsaros, Dionyssios; Panini, Nicolò; Bianchi, Tommaso; Landoni, Fabio; Miozzo, Monica; D'Incalci, Maurizio; Brenton, James D; Romualdi, Chiara; Marchini, Sergio.
Afiliação
  • Pesenti C; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
  • Beltrame L; IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Velle A; Department of Biology, University of Padova, Padova, Italy.
  • Fruscio R; Department of Obstetrics and Gynaecology, Università Degli Studi Milano-Bicocca, San Gerardo Hospital, Monza, Italy.
  • Jaconi M; Department of Pathology, Università Degli Studi Milano-Bicocca, San Gerardo Hospital, Monza, Italy.
  • Borella F; Gynecology and Obstetrics 1, Department of Surgical Sciences, San Anna Hospital, University of Torino, Torino, Italy.
  • Cribiù FM; Division of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Calura E; Department of Biology, University of Padova, Padova, Italy.
  • Venturini LV; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
  • Lenoci D; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
  • Agostinis F; Department of Biology, University of Padova, Padova, Italy.
  • Katsaros D; AOU City of Health, Dept of Surgical Sciences, Gynecology, St Anna Hospital and University of Torino, Torino, Italy.
  • Panini N; Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
  • Bianchi T; Department of Obstetrics and Gynaecology, Università Degli Studi Milano-Bicocca, San Gerardo Hospital, Monza, Italy.
  • Landoni F; Department of Obstetrics and Gynaecology, Università Degli Studi Milano-Bicocca, San Gerardo Hospital, Monza, Italy.
  • Miozzo M; Department of Health Sciences, Medical Genetics, Università Degli Studi di Milano, Milano, Italy; Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • D'Incalci M; Laboratory of Cancer Pharmacology, IRCCS Humanitas Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy. Electronic address: maurizio.dincalci@hunimed.eu.
  • Brenton JD; Cancer Research UK Cambridge Research Institute, University of Cambridge, Cambridge, UK.
  • Romualdi C; Department of Biology, University of Padova, Padova, Italy.
  • Marchini S; IRCCS Humanitas Research Hospital, Rozzano, Italy.
Eur J Cancer ; 171: 85-95, 2022 08.
Article em En | MEDLINE | ID: mdl-35714451
ABSTRACT

BACKGROUND:

Stage I epithelial ovarian cancer (EOC) encompasses five histologically different subtypes of tumors confined to the ovaries with a generally favorable prognosis. Despite the intrinsic heterogeneity, all stage I EOCs are treated with complete resection and adjuvant therapy in most of the cases. Owing to the lack of robust prognostic markers, this often leads to overtreatment. Therefore, a better molecular characterization of stage I EOCs could improve the assessment of the risk of relapse and the refinement of optimal treatment options. MATERIALS AND

METHODS:

205 stage I EOCs tumor biopsies with a median follow-up of eight years were gathered from two independent Italian tumor tissue collections, and the genome distribution of somatic copy number alterations (SCNAs) was investigated by shallow whole genome sequencing (sWGS) approach.

RESULTS:

Despite the variability in SCNAs distribution both across and within the histotypes, we were able to define three common genomic instability patterns, namely stable, unstable, and highly unstable. These patterns were based on the percentage of the genome affected by SCNAs and on their length. The genomic instability pattern was strongly predictive of patients' prognosis also with multivariate models including currently used clinico-pathological variables.

CONCLUSIONS:

The results obtained in this study support the idea that novel molecular markers, in this case genomic instability patterns, can anticipate the behavior of stage I EOC regardless of tumor subtype and provide valuable prognostic information. Thus, it might be propitious to extend the study of these genomic instability patterns to improve rational management of this disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Variações do Número de Cópias de DNA Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Variações do Número de Cópias de DNA Idioma: En Ano de publicação: 2022 Tipo de documento: Article